Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — Juli 2017

Planlagt Fastgjort Låst Flyttet Genmab
985 Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • S Offline
    S Offline
    Sukkeralf
    wrote on sidst redigeret af
    #967

    hov - blev lige afbrud - jo 2025-2027 stykker

    1 Reply Last reply
    0
    • StockBullS Offline
      StockBullS Offline
      StockBull
      wrote on sidst redigeret af
      #968

      Beklager min fejl information. Det Michael Novod har informeret at M.M markedet vil være ca. 9B USD i 2020 og det er sikkert revideret efter denne artikel fra 2013 http://www.firstwordpharma.com/node/1066623?tsid=21#axzz4oOXUDX45

      1 Reply Last reply
      0
      • G Offline
        G Offline
        gentogen
        wrote on sidst redigeret af
        #969

        The global multiple myeloma therapeutics market was valued at USD 7.5 billion in 2015 and is expected to reach a value of USD 37.5 billion by 2024. Key factors driving the market expansion include constant introduction of newer and effective therapeutic options and high adoption rates of the same.

        1 Reply Last reply
        0
        • G Offline
          G Offline
          gentogen
          wrote on sidst redigeret af
          #970

          Just a moment...

          favicon

          (www.grandviewresearch.com)

          1 Reply Last reply
          0
          • G Offline
            G Offline
            gentogen
            wrote on sidst redigeret af
            #971

            Men der er mange bud.....http://www.fiercepharma.com/marketing/global-multiple-myeloma-treatment-market-value-to-approach-9-billion-by-2021-says-gbi

            1 Reply Last reply
            0
            • H Offline
              H Offline
              Her_for_at_lære
              wrote on sidst redigeret af
              #972

              Der er an meget afventende handel med Genmap. Er det mon udtryk for en afventen med hensyn til halvårsregnskabet den 9. Aug?

              1 Reply Last reply
              0
              • SolsenS Offline
                SolsenS Offline
                Solsen
                wrote on sidst redigeret af
                #973

                Sommerferie...

                1 Reply Last reply
                0
                • H Offline
                  H Offline
                  Her_for_at_lære
                  wrote on sidst redigeret af
                  #974

                  OK 🙂

                  1 Reply Last reply
                  0
                  • T Offline
                    T Offline
                    transalp
                    wrote on sidst redigeret af
                    #975

                    favicon

                    (www.bloodjournal.org)

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      JKY_VH
                      wrote on sidst redigeret af
                      #976

                      God eftermiddag. Der er nok at glæde sig til i den kommende tid: Q3-2017: Darzalex ph III ALCYONE frontline MM data with Velcade
                      H2 2017: ESMO Congress – 8-12 September
                      H2 2017: Ph II data for Tisotumab Vedotin (likely at ESMO)
                      H2 2017: Darzalex Ph II data in high-risk smouldering myeloma
                      (CENTAURUS study) likely in Q4 (ASH)
                      H2 2017: Darzalex ph II data in multiple myeloma with Celgene’s
                      durvalumab
                      H1 2018: Darzalex ph III MAIA frontline MM data with Revlimid

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        JKY_VH
                        wrote on sidst redigeret af
                        #977

                        H1 2018: Darzalex ph Ib/II data in solid tumours with Roche's
                        checkpoint inhibitor Tecentriq
                        H2 2018: Darzalex ph Ib/II data in solid tumours with BMS's
                        checkpoint inhibitor Opdivo.
                        Kilde: Nordea

                        1 Reply Last reply
                        0
                        • E Offline
                          E Offline
                          E_L
                          wrote on sidst redigeret af
                          #978

                          Since you mentioned durvalumab, had news today: IMFINZI™ (durvalumab) granted Breakthrough Therapy Designation by US FDA for patients with locally advanced unresectable non-small cell lung cancer https://www.astrazeneca-us.com/media/press-releases/2017/imfinzi-durvalumab-granted-breakthrough-therapy-designation-by-us-fda-for-patients-with-locally-advanced-unresectable-non-small-cell-lung-cancer-07312017.html

                          1 Reply Last reply
                          0
                          • J Offline
                            J Offline
                            JKY_VH
                            wrote on sidst redigeret af
                            #979

                            Thank you E L

                            1 Reply Last reply
                            0
                            • DarvinD Offline
                              DarvinD Offline
                              Darvin
                              wrote on sidst redigeret af
                              #980

                              Mht snakken ca kl 10.00 - Novod forventer Dara passerer 5,3 mia i salg 2021 alene i MM. CITI at knap 6 mia passeres i 2021 også i MM. CITI siger totalmarked i 2025 for US (MM) alene vil være 28 mia $ og at verdensmarkedet umiddelbart (normalt) bliver det dobbelte!! (46 mia). Så kan man jo tænke lidt på markedsandel for DARA. CITI regner med 11 mia i topsalg for Dara, men der er mange faktorer

                              1 Reply Last reply
                              0
                              • M Offline
                                M Offline
                                Mcjean
                                wrote on sidst redigeret af
                                #981

                                11 mia$ eller?, altså omkring 18% af 70 mia, ca. 13 mia kr. ved markedsandel på ca. 25%, lavt sat hvis sc og vedligeholdelse medregnes og udløb af to patenter. For 13 mia kr. om året kan der nok købes en del, måske en ny fabrik måske:-)

                                1 Reply Last reply
                                0
                                • B Offline
                                  B Offline
                                  bibob
                                  wrote on sidst redigeret af
                                  #982

                                  Ja Mcjean. Mon ikke pølsemanden havde råd til at modernisere pølsevognen hvis han havde den omsætning. 😄

                                  1 Reply Last reply
                                  0
                                  • B Offline
                                    B Offline
                                    bikube
                                    wrote on sidst redigeret af
                                    #983

                                    Mcjean - skal du over knæet - fy skam dig.

                                    1 Reply Last reply
                                    0
                                    • I Offline
                                      I Offline
                                      ienk1
                                      wrote on sidst redigeret af
                                      #984

                                      Måske Lisa som konsulent i indkørselsfasen 😉

                                      1 Reply Last reply
                                      0
                                      • I Offline
                                        I Offline
                                        ienk1
                                        wrote on sidst redigeret af
                                        #985

                                        Med

                                        1 Reply Last reply
                                        0
                                        • H Offline
                                          H Offline
                                          Hitshark
                                          wrote on sidst redigeret af
                                          #986

                                          er blitt spurt tidligere men hvilken tid kommer kvartalsrapporten 9 aug?

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger